Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B ROTHMAN

Showing results (491-500 of 606) with videos related to

Pageof 61
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1992
Characterization of the enantiomers of cis-N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1- pyrrolidinyl)cyclohexylamine (BD737 and BD738): novel compounds with high affinity, selectivity and biological efficacy at sigma receptorsW D Bowen, J M Walker, B R de Costa, et al.
Plos One|April 6, 2011
Altered gene expression in pulmonary tissue of tryptophan hydroxylase-1 knockout mice: implications for pulmonary arterial hypertensionRichard B Rothman, Jean L Cadet, Christina M Dersch, et al.
Journal of Medicinal Chemistry|December 10, 1999
Oxygenated analogues of 1-[2-(Diphenylmethoxy)ethyl]- and 1-[2-[Bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) as potential extended-action cocaine-abuse therapeutic agentsD B Lewis, D Matecka, Y Zhang, et al.
Synapse (New York, N.Y.)|July 27, 1999
GBR12909 attenuates amphetamine-induced striatal dopamine release as measured by [(11)C]raclopride continuous infusion PET scansV L Villemagne, D F Wong, F Yokoi, et al.
Journal of Medicinal Chemistry|February 28, 1997
Heteroaromatic analogs of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) as high-affinity dopamine reuptake inhibitorsD Matecka, D Lewis, R B Rothman, et al.
Neurochemical Research|April 1, 1994
An electrophilic affinity ligand based on (+)-MK801 distinguishes PCP site 1 from PCP site 2H C Akunne, J A Monn, A Thurkauf, et al.
Journal of Medicinal Chemistry|September 6, 2002
Piperidine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR 12909): high affinity ligands for the dopamine transporterThomas Prisinzano, Elisabeth Greiner, Edward M Johnson, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2001
A genomic approach to gene fusion technologyT K Van Dyk, Y Wei, M K Hanafey, et al.
Journal of Medicinal Chemistry|April 28, 1995
Probes for narcotic receptor-mediated phenomena. 20. Alteration of opioid receptor subtype selectivity of the 5-(3-hydroxyphenyl)morphans by application of the message-address concept: preparation of delta-opioid receptor ligandsC M Bertha, J L Flippen-Anderson, R B Rothman, et al.
Pharmacology, Biochemistry, and Behavior|October 1, 1991
GBR12909 antagonizes the ability of cocaine to elevate extracellular levels of dopamineR B Rothman, A Mele, A A Reid, et al.
Pageof 61

Showing results (491-500 of 606) with videos related to

Sort By:
Pageof 61
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1992
Characterization of the enantiomers of cis-N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1- pyrrolidinyl)cyclohexylamine (BD737 and BD738): novel compounds with high affinity, selectivity and biological efficacy at sigma receptorsW D Bowen, J M Walker, B R de Costa, et al.
Plos One|April 6, 2011
Altered gene expression in pulmonary tissue of tryptophan hydroxylase-1 knockout mice: implications for pulmonary arterial hypertensionRichard B Rothman, Jean L Cadet, Christina M Dersch, et al.
Journal of Medicinal Chemistry|December 10, 1999
Oxygenated analogues of 1-[2-(Diphenylmethoxy)ethyl]- and 1-[2-[Bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) as potential extended-action cocaine-abuse therapeutic agentsD B Lewis, D Matecka, Y Zhang, et al.
Synapse (New York, N.Y.)|July 27, 1999
GBR12909 attenuates amphetamine-induced striatal dopamine release as measured by [(11)C]raclopride continuous infusion PET scansV L Villemagne, D F Wong, F Yokoi, et al.
Journal of Medicinal Chemistry|February 28, 1997
Heteroaromatic analogs of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) as high-affinity dopamine reuptake inhibitorsD Matecka, D Lewis, R B Rothman, et al.
Neurochemical Research|April 1, 1994
An electrophilic affinity ligand based on (+)-MK801 distinguishes PCP site 1 from PCP site 2H C Akunne, J A Monn, A Thurkauf, et al.
Journal of Medicinal Chemistry|September 6, 2002
Piperidine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR 12909): high affinity ligands for the dopamine transporterThomas Prisinzano, Elisabeth Greiner, Edward M Johnson, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2001
A genomic approach to gene fusion technologyT K Van Dyk, Y Wei, M K Hanafey, et al.
Journal of Medicinal Chemistry|April 28, 1995
Probes for narcotic receptor-mediated phenomena. 20. Alteration of opioid receptor subtype selectivity of the 5-(3-hydroxyphenyl)morphans by application of the message-address concept: preparation of delta-opioid receptor ligandsC M Bertha, J L Flippen-Anderson, R B Rothman, et al.
Pharmacology, Biochemistry, and Behavior|October 1, 1991
GBR12909 antagonizes the ability of cocaine to elevate extracellular levels of dopamineR B Rothman, A Mele, A A Reid, et al.
Pageof 61